Showing results (411-420 of 520) with videos related to
Sort By:
Pageof 52
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 6, 2019
Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-AnalysisPrashanth Rawla, Marie Line El Helou, Anantha R VellipuramCardiovascular & Hematological Agents in Medicinal Chemistry|August 24, 2025
The Antioxidant and Anti-lipidemic Potential of Angiotensin-converting Enzyme Inhibitor (Ramipril) in L-NAME Hypertensive RatsEsther Oluwasola Aluko, Ezekiel Etim Ben, Grace Edet BasseyCardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2006
Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damageAnna M Grandi, Andrea M MarescaCardiovascular & Hematological Agents in Medicinal Chemistry|July 18, 2006
Dietary fat and hypertension: a novel approach through the proteolytic regulatory enzymes of the renin-angiotensin-systemJ M Martínez-Martos, M J Ramírez-ExpósitoCardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapyGiovanni Anfossi, Mariella TrovatiCardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
COX-inhibiting nitric oxide donors (CINODs): potential benefits on cardiovascular and renal functionMarcelo N Muscará, John L WallaceCardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
The role of thrombomodulin in atherosclerosis: from bench to bedsideYi-Heng Li, Guey-Yueh Shi, Hua-Lin WuCardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2007
Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promisesSilvia Nistri, Mario Bigazzi, Daniele BaniCardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2007
Integrins: novel therapeutic targets for cardiovascular diseasesHind Lal, Rakeshwar S Guleria, Donald M Foster, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|July 17, 2007
JAK2 as a molecular marker in myeloproliferative diseasesR Mata, D Subirá, A García-Raso, et al.Pageof 52